Henry J. Fuchs, Director at Mirati Therapeutics, Inc. (MRTX), sold 12,300 shares at $127.52 ($1.6M) on 2020-08-10, disclosed to the SEC on 2020-08-11.
Open-market sale of $1.6M MRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $127.52 | 500 | $64K | 4.0% |
| 2 | $128.56 | 900 | $116K | 7.2% |
| 3 | $129.80 | 1,000 | $130K | 8.0% |
| 4 | $129.80 | 1,000 | $130K | 8.0% |
| 5 | $131.08 | 1,300 | $170K | 10.6% |
| 6 | $131.08 | 1,300 |
| $170K |
| 10.6% |
| 7 | $132.34 | 5,800 | $768K | 47.6% |
| 8 | $133.07 | 500 | $67K | 4.1% |
| Total | $131.22 avg | 12,300 | $1.6M | 100% |
| Filing → |
| MRTX | SELL | 2022-02-14 | $1.4M | — | Filing → |
| MRTX | SELL | 2020-12-16 | $4.7M | — | Filing → |
| BMRN | SELL | 2020-07-22 | $16.4M | — | Filing → |